Further study and extensive clinical investigations are necessary to assess the therapeutic efficacy of serum albumin levels in predicting the outcomes of ischemic strokes and determining their suitability for inclusion in standard stroke therapy. This evidence concerns the gene ALB and ischemic stroke.